LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 71 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $316,000 | -25.1% | 98,941 | 0.0% | 0.00% | – |
Q1 2022 | $422,000 | -4.5% | 98,941 | +4.2% | 0.00% | – |
Q4 2021 | $442,000 | +18.5% | 94,979 | +1.6% | 0.00% | – |
Q3 2021 | $373,000 | -6.8% | 93,479 | 0.0% | 0.00% | – |
Q2 2021 | $400,000 | -76.1% | 93,479 | -76.4% | 0.00% | – |
Q1 2021 | $1,677,000 | -2.2% | 395,520 | -10.4% | 0.00% | – |
Q4 2020 | $1,714,000 | +4.3% | 441,651 | +8.2% | 0.00% | – |
Q3 2020 | $1,644,000 | -4.9% | 408,031 | +0.6% | 0.00% | – |
Q2 2020 | $1,728,000 | +0.5% | 405,606 | -0.9% | 0.00% | – |
Q1 2020 | $1,720,000 | +2.0% | 409,448 | -4.6% | 0.00% | – |
Q4 2019 | $1,686,000 | -55.2% | 429,058 | +0.4% | 0.00% | – |
Q3 2019 | $3,762,000 | -2.2% | 427,553 | +2.9% | 0.00% | – |
Q2 2019 | $3,845,000 | +40.7% | 415,663 | -2.2% | 0.00% | – |
Q1 2019 | $2,733,000 | -28.9% | 425,017 | +4.3% | 0.00% | – |
Q4 2018 | $3,842,000 | -88.4% | 407,397 | -75.3% | 0.00% | -100.0% |
Q3 2018 | $33,153,000 | -25.3% | 1,647,117 | +8.3% | 0.00% | -25.0% |
Q2 2018 | $44,367,000 | +0.6% | 1,520,888 | +2.7% | 0.00% | 0.0% |
Q1 2018 | $44,086,000 | +60.0% | 1,480,288 | +72.9% | 0.00% | +100.0% |
Q4 2017 | $27,551,000 | +6.1% | 856,186 | +14.7% | 0.00% | 0.0% |
Q3 2017 | $25,963,000 | -26.1% | 746,492 | -36.8% | 0.00% | -33.3% |
Q2 2017 | $35,140,000 | +234.1% | 1,180,368 | +235.1% | 0.00% | +200.0% |
Q1 2017 | $10,519,000 | +163.5% | 352,287 | +54.8% | 0.00% | – |
Q4 2016 | $3,992,000 | -21.6% | 227,561 | +6.3% | 0.00% | -100.0% |
Q3 2016 | $5,094,000 | +50.4% | 214,066 | +1.1% | 0.00% | – |
Q2 2016 | $3,387,000 | -24.8% | 211,786 | -1.7% | 0.00% | – |
Q1 2016 | $4,503,000 | -63.6% | 215,413 | -53.0% | 0.00% | -100.0% |
Q4 2015 | $12,374,000 | +163.3% | 458,374 | +171.0% | 0.00% | 0.0% |
Q3 2015 | $4,699,000 | +102.3% | 169,152 | +78.6% | 0.00% | – |
Q2 2015 | $2,323,000 | – | 94,731 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |